Product review updates
Our April 2024 edition of Analysis covers all the product updates you need to know about when they come in to effect from 1 April 2024.
In this product review, we’ve worked on wording within our customer documents and communications to provide clarity around our cover for comparable procedures and drugs. We are also continuing our work to ensure that our services are accessible and easily understood for all customers.
If you have any questions about the changes in this update, please contact your AXA Health Relationship Manager.
Download your copy of Product Review Analysis April 2024 here.
Broker Support
In November, representatives of AXA Health joined women's health advocacy groups at the UK Parliament, in an effort to raise awareness of the unique health challenges faced by women.
Read moreBroker Support
The healthcare landscape as we’ve known it is continually evolving. Listen to our latest broker strategic briefing to hear our priorities and vision for the year ahead.
Read moreBroker Support
Our latest mind health workplace insights show one in two 18-24-year-olds feel lonely some or all the time and report the highest rates of social isolation.
Read moreBroker Support
Product Review Analysis for October 2024 is now ready to download.
Read moreBroker Support
Looking ahead to the near future, age and lifestyle related diseases are set to rise and demand on primary care services continue to grow. Watch our webinar 'Shaping healthcare for today and tomorrow' as we explore this topic.
Read moreBroker Support
AXA Health has announced the acquisition of HBSUK, an online outpatient service provider which helps to deliver safe and effective treatment in a fast and efficient way.
Read moreBroker Support
Product Review Analysis for April 2024 is now ready to download.
Read moreBroker Support
The 24/7 health support can help your clients' employees with everything from heart, diabetes, and cancer concerns, to upcoming treatments, or questions about their medicine – no matter the time of day. We interviewed Lane Wells (RGN), to find out more about the service.
Read moreBroker Support
With 52% of patients currently left waiting over a year for an autism assessment and 40% for an ADHD assessment, the need for more employers to offer access to assessment and support for neurodiversity remains pressing. Find out more about our service one year on and how we can help your clients.
Read moreBroker Support
Paul Moulton, SME and Corporate Distribution Director at AXA Health discusses why insurers are seeing growing employer demand for PMI, despite challenging economic conditions.
Read moreBroker Support
Research reveals that people reaching the point of burnout and work-related stress is a significant issue for the UK economy. Katie Plascott, Corporate Marketing Consultant at AXA Health looks at why it's never been more important to get wellbeing right.
Read more